Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:45 AM
Ignite Modification Date:
2025-12-25 @ 12:45 AM
NCT ID:
NCT07263867
Eligibility Criteria:
Inclusion Criteria:
1. Age ≥18 years
2. Hospitalized patients (inpatients)
3. Scheduled for therapeutic colonoscopy (polypectomy, endoscopic mucosal resection \[EMR\], endoscopic submucosal dissection \[ESD\], or biopsy for diagnosis)
4. Time from admission to scheduled colonoscopy ≥48 hours (allowing adequate preparation time)
5. Patient or legal representative able to provide written informed consent
6. Able to understand and follow bowel preparation instructions (with assistance from caregivers if needed)
Exclusion Criteria:
1. Emergency gastrointestinal conditions: bowel obstruction, acute lower gastrointestinal bleeding requiring urgent intervention, suspected or confirmed perforation
2. Emergency or same-day colonoscopy (scheduled \<24 hours after admission)
3. History of total colectomy or current colostomy/ileostomy
4. Severe cognitive impairment (Mini-Cog score 0-1 or MMSE \<18) without available caregiver
5. Severe cardiopulmonary disease: New York Heart Association (NYHA) Class IV heart failure, chronic kidney disease (CKD) stage 4-5 (eGFR \<30 ml/min/1.73m²) unable to tolerate PEG-based preparation
6. Known or suspected pregnancy, currently breastfeeding
7. Previous severe allergic reaction to PEG or bowel preparation agents
8. Current participation in another interventional clinical trial
9. Unable to provide informed consent and no legal representative available
10. Patient or legal representative declines participation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07263867
Study Brief:
Protocol Section:
NCT07263867